United States Heartworm Treatment Market Size, Competitive Landscape and Market Forecast - 2029

United States Heartworm Treatment Market is segmented By Product Type (Fluralaner (BRAVECTO), Broadline (fipronil, (s)-methoprene, eprinomectin, praziquantel), Simparica Trio™ (sarolaner, moxidectin, and pyrantel chewable tablets), ProHeart 12 (moxidectin), Revolution/Stronghold Plus (selamectin/sarolaner), VETHICAL (ivermectin/pyrantel pamoate/praziquantel), Trifexis, Advantage Multi, Heartgard Chewables, Interceptor, Iverhart, Sentinel, Tri-Heart Plus Chew), By End-User (Dogs, Cats, Others), By Distribution Channel (Veterinary Hospitals & Clinics, Pharmacies, Online Pharmacies, Others)  By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029

The "United States Heartworm Treatment Market" is expected to grow at a high CAGR during the forecasting period (2022-2029).

United States Heartworm Treatment Market Scope

Metrics	Details
Market CAGR	High
Segments Covered	By Product,  By End-User, By Application, and By Region
Report Insights Covered	Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.
Fastest Growing Region	Asia Pacific
Largest Market Share	North America

Get A Free Sample Click Here

Heartworm disease is generally found in pets, including cats and dogs, which could be fatal in severe conditions.

The pets are affected by heartworm disease owing to mosquitoes that carry heartworm larvae. It may cause several health issues, making heartworm treatment highly crucial which cannot be ignored. The growing adoption of pets and raising awareness of such diseases are expected to increase heartworm treatment measures.

The market for heartworm treatment is projected to witness significant growth in the coming years with rising demand for animal welfare and increasing incidence of fatal diseases in pets.

The rising incidence of disease in animals and the implementation of stringent regulations to prevent animal diseases drive the heartworm treatment market's growth. The increasing demand for pet health insurance and rising healthcare expenditure further boost the heartworm treatment market.

Heartworm treatment deals with the prevention and treatment of heartworm diseases. The overall veterinary treatment market has been growing in the past few years due to the increasing awareness of veterinary healthcare. Heartworm disease is a severe, fatal disease, which is generally found in pets. Heartworm disease is usually caused by foot-long worms present in the lungs, heart, and associated blood vessels of affected pets.

Heartworm disease causes severe heart failure, lung disease, and damage to other organs in the body. Heartworm disease affects pets like cats, dogs, and ferrets. These worms live in other mammal species such as coyotes, wolves, sea lions, foxes, etc.

Species like coyotes and foxes live in proximity to many urban areas. Thus, they are considered as important carriers of heartworm disease. Dogs are considered to be a natural host for heartworms. It has also been found that heartworm disease in cats is very different from heartworm disease in dogs. Cats are a typical host for heartworms. Heartworm disease symptoms include a mild persistent cough, fatigue after moderate activity, reluctance to exercise, weight loss, and decreased appetite.

Heartworms are spread through the bites of mosquitos that carry the infective heartworm larvae. The larvae continue to mature in the dog’s heart and lungs. Dogs are usually treated with three injections, namely: melarsomine, doxycycline, and prednisone. The melarsomine injection kills the adult heartworms and reduces the chances of unwanted side effects. Moreover, a severe heartworm disease case requires surgery to remove the worms from the heart and vessels within the lungs. Melarsomine injections are not recommended for use in cats. Melarsomine is a prescription drug that can only be obtained from a veterinarian. Monthly preventive medication prescribed by a veterinarian protects most owned pets from this disease.

Why Purchase the Report?

• Visualize the Heartworm Treatment market's composition across each indication regarding type and application, highlighting the critical commercial assets and players.
• Identify business opportunities in the Heartworm Treatment market by analyzing trends and co-development deals.
• Excel data sheet with thousands of data points of the Heartworm Treatment market-level 4/5 segmentation
• PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study
• Product mapping in excel for the key Heartworm Treatment market products of all major market players.

Target Audience

• Raw Material Suppliers/ Buyers
• Product Suppliers/ Buyers
• Industry Investors/Investment Bankers
• Education & Research Institutes
• Research Professionals
• Emerging Companies
• Manufacturers

Frequently Asked Questions

What is the Projected CAGR value of the United States Heartworm Treatment Market?

United States Heartworm Treatment Market is expected to grow at a CAGR of high during the forecasting period 2022-2029.

Which region controlled the global market during 2022-2029?

North America region Controls the United States Heartworm Treatment Market during 2022-2029.

Which is the fastest growing region in the United States Heartworm Treatment Market?

Among all regions, Asia Pacific is the fastest growing market share during the forecast period.

Trending Topics

Veterinary Vaccines Market

Veterinary Pain Management Market